These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 702768)

  • 21. [Cardiovascular action of vincamine hydrochloride].
    Piacenza G; Pesce E; Marchini F
    Farmaco Prat; 1978 Jul; 33(7):306-18. PubMed ID: 744231
    [No Abstract]   [Full Text] [Related]  

  • 22. Cerebral metabolic and hemodynamic activities of l-eburnamonine in the anesthetized dog. A comparison with vincamine.
    Lacroix P; Quiniou MJ; Linee P; Le Polles JB
    Arzneimittelforschung; 1979; 29(8):1094-101. PubMed ID: 40580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of vincamine on the regional cerebral blood flow in man.
    Depresseux JC
    Eur Neurol; 1978; 17(2):100-7. PubMed ID: 631141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulatory effect of ethanol, with special reference to cerebral circulation.
    Miyazaki M
    Jpn Circ J; 1974 May; 38(5):381-5. PubMed ID: 4431089
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia.
    Hagstadius S; Gustafson L; Risberg J
    Psychopharmacology (Berl); 1984; 83(4):321-6. PubMed ID: 6436861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium modulation and clinical effect. Profile of cyclandelate.
    Timmerman H
    Drugs; 1987; 33 Suppl 2():1-4. PubMed ID: 3622303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacodynamics of the cerebral circulation. Results of a study on the action of 10 drugs on cerebral blood flow and energy metabolism in cerebrovascular patients].
    Marc-Vergnes JP; Bes A; Charlet JP; Delpla M; Richardot JP; Géraud J
    Pathol Biol (Paris); 1974 Nov; 22(9):815-25. PubMed ID: 4216872
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of human platelet aggregation by cyclandelate.
    Van den Hoven WE; Hall DW
    Br J Clin Pract Suppl; 1984; 34():34-8. PubMed ID: 6430321
    [No Abstract]   [Full Text] [Related]  

  • 31. Calcium antagonistic action involved in vasodilation by brovincamine.
    Katsuragi T; Ohba M; Mori R; Kushiku K; Furukawa T
    Gen Pharmacol; 1984; 15(1):43-5. PubMed ID: 6698382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of vincamine on cerebral blood flow as a function of application rate (author's transl)].
    Heiss WD; Podreka I; Samec P
    Arzneimittelforschung; 1977; 27(6a):1291-3. PubMed ID: 578455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate.
    Timmerman H
    Br J Clin Pract Suppl; 1984; 34():10-9. PubMed ID: 6430317
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of various vasodilatory drugs on the cerebral circulation in rabbits and rats.
    Reichl R; Hutten H; Vaupel P
    Bibl Anat; 1979; (18):236-8. PubMed ID: 496838
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative study of the clinical effect of vincamine versus papaverine given parenterally in the acute phase of stroke.
    Thiery E; Otte G; Vander Eecken H
    Arzneimittelforschung; 1979; 29(3):671-4. PubMed ID: 582751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cerebral hemodynamic effect of Vincamine.
    Depresseux JC
    Acta Neurol Scand Suppl; 1977; 64():408-9. PubMed ID: 268852
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclandelate and a number of its metabolites inhibit discocyte-echinocyte transformations of human erythrocytes.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():26-30. PubMed ID: 6430318
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral vasodilators (second of two parts).
    Cook P; James I
    N Engl J Med; 1981 Dec; 305(26):1560-4. PubMed ID: 7031468
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclandelate: calcium modulation and clinical effects. Proceedings of a symposium. Helsinki, 14-15 November, 1986.
    Drugs; 1987; 33 Suppl 2():1-141. PubMed ID: 3622302
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of cyclandelate on regional cerebral blood flow measured by intracarotid injection of Xe133].
    Yoshida K; Ishijima Y; Matsuda M
    Nihon Geka Hokan; 1968 Nov; 37(6):842-53. PubMed ID: 5751725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.